In vivo mutagenicity of benzo[f]quinoline, benzo[h]quinoline, and 1,7-phenanthroline using the lacZ transgenic mice. 2004

Katsuya Yamada, and Takayoshi Suzuki, and Arihiro Kohara, and Makoto Hayashi, and Takaharu Mizutani, and Ken-Ichi Saeki
Graduate School of Pharmaceutical Sciences, Nagoya City University, Tanabedori, Mizuho-ku, Nagoya 467-8603, Japan.

Phenanthrene, a simplest angular polycyclic aromatic hydrocarbon with a bay-region in its molecule, is reported to be non-mutagenic, although most angular (non-linear) polycyclic aromatic hydrocarbons, such as benzo[a]pyrene and chrysene, are known to show genotoxicity after metabolic transformation into a bay-region diol epoxide. On the other hand, benzo[f]quinoline (BfQ), benzo[h]quinoline (BhQ), and 1,7-phenanthroline (1,7-Phe), which are all aza-analogs of phenanthrene, are mutagenic in the Ames test using Salmonella typhimurium TA100 in the presence of a rat liver S9 fraction. In this report, we undertook to investigate the in vivo mutagenicity of BfQ, BhQ and 1,7-Phe by an in vivo mutation assay system using the lacZ transgenic mouse (Muta Mouse). BfQ and BhQ only slightly induced mutation in the liver and lung, respectively. BfQ- and BhQ-induced cII mutant spectra showed no characteristics compared with that of the control. These results suggest that the in vivo mutagenicities of BfQ and BhQ were equivocal. On the other hand, 1,7-Phe induced a potent mutation in the liver and a weak mutation in the lung. Furthermore 1,7-Phe depressed the G:C to A:T transition and increased the G:C to C:G transversion in the liver like quinoline, a hepatomutagen possessing the partial structure of 1,7-Phe, compared with the spontaneous mutation spectrum. These results suggest that the in vivo mutagenicity of 1,7-Phe might be caused by the same mechanism as that of quinoline, which induced the same mutational spectrum change (G:C to C:G transversion).

UI MeSH Term Description Entries
D007763 Lac Operon The genetic unit consisting of three structural genes, an operator and a regulatory gene. The regulatory gene controls the synthesis of the three structural genes: BETA-GALACTOSIDASE and beta-galactoside permease (involved with the metabolism of lactose), and beta-thiogalactoside acetyltransferase. Lac Gene,LacZ Genes,Lactose Operon,Gene, Lac,Gene, LacZ,Genes, Lac,Genes, LacZ,Lac Genes,Lac Operons,LacZ Gene,Lactose Operons,Operon, Lac,Operon, Lactose,Operons, Lac,Operons, Lactose
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008822 Mice, Transgenic Laboratory mice that have been produced from a genetically manipulated EGG or EMBRYO, MAMMALIAN. Transgenic Mice,Founder Mice, Transgenic,Mouse, Founder, Transgenic,Mouse, Transgenic,Mice, Transgenic Founder,Transgenic Founder Mice,Transgenic Mouse
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009152 Mutagenicity Tests Tests of chemical substances and physical agents for mutagenic potential. They include microbial, insect, mammalian cell, and whole animal tests. Genetic Toxicity Tests,Genotoxicity Tests,Mutagen Screening,Tests, Genetic Toxicity,Toxicity Tests, Genetic,Genetic Toxicity Test,Genotoxicity Test,Mutagen Screenings,Mutagenicity Test,Screening, Mutagen,Screenings, Mutagen,Test, Genotoxicity,Tests, Genotoxicity,Toxicity Test, Genetic
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010618 Phenanthrolines Phenanthroline
D011804 Quinolines

Related Publications

Katsuya Yamada, and Takayoshi Suzuki, and Arihiro Kohara, and Makoto Hayashi, and Takaharu Mizutani, and Ken-Ichi Saeki
January 1989, Cancer research,
Katsuya Yamada, and Takayoshi Suzuki, and Arihiro Kohara, and Makoto Hayashi, and Takaharu Mizutani, and Ken-Ichi Saeki
May 2005, Applied microbiology and biotechnology,
Katsuya Yamada, and Takayoshi Suzuki, and Arihiro Kohara, and Makoto Hayashi, and Takaharu Mizutani, and Ken-Ichi Saeki
August 2009, Assay and drug development technologies,
Katsuya Yamada, and Takayoshi Suzuki, and Arihiro Kohara, and Makoto Hayashi, and Takaharu Mizutani, and Ken-Ichi Saeki
May 1998, Mutation research,
Katsuya Yamada, and Takayoshi Suzuki, and Arihiro Kohara, and Makoto Hayashi, and Takaharu Mizutani, and Ken-Ichi Saeki
March 1998, Mutagenesis,
Katsuya Yamada, and Takayoshi Suzuki, and Arihiro Kohara, and Makoto Hayashi, and Takaharu Mizutani, and Ken-Ichi Saeki
January 1998, Mutagenesis,
Katsuya Yamada, and Takayoshi Suzuki, and Arihiro Kohara, and Makoto Hayashi, and Takaharu Mizutani, and Ken-Ichi Saeki
May 1997, Toxicology letters,
Katsuya Yamada, and Takayoshi Suzuki, and Arihiro Kohara, and Makoto Hayashi, and Takaharu Mizutani, and Ken-Ichi Saeki
September 1983, Carcinogenesis,
Katsuya Yamada, and Takayoshi Suzuki, and Arihiro Kohara, and Makoto Hayashi, and Takaharu Mizutani, and Ken-Ichi Saeki
May 1996, The Journal of organic chemistry,
Katsuya Yamada, and Takayoshi Suzuki, and Arihiro Kohara, and Makoto Hayashi, and Takaharu Mizutani, and Ken-Ichi Saeki
February 1998, Mutation research,
Copied contents to your clipboard!